Search tips
Search criteria 


Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Neurol Neurosurg Psychiatry. 1987 May; 50(5): 523–531.
PMCID: PMC1031962

Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.


The mean survival period in a series of 216 multiple sclerosis deaths, which formed part of a large prevalence sample observed in the Grampian region of Scotland, was 24.5 years, with an insignificant difference between females (25.7 years) and males (23.5 years). A third of the patients survived for over 30 years after onset. The age at death ranged between 25-80 years, with majority of the deaths occurring in the seventh decade (37%). On comparing life expectancy with the Scottish general population using life tables, only a slight reduction in the short-term (less than 10 years from onset) survival was noted in all age groups, with the exception of those with onset over the age of 50 years. The long-term life expectancy was however markedly reduced in all age groups compared with the controls. The survival period could be accurately predicted from the degree of disability at a point in time, and could be correlated with a number of clinical features, the most important of which was the age at onset. Eighty five per cent of those with onset of multiple sclerosis over the age of 50 years died within 20 years. Patients with a cerebellar disturbance at onset survived the shortest, and those with a brainstem lesion or retrobulbar neuritis the longest; those with a pyramidal dysfunction had an intermediate prognosis. Other parameters which could be correlated with the survival were: the timing and frequency of occurrence of psychiatric and urinary symptoms, interval between onset and first relapse and the course of the disease. As expected, most patients (89%) were significantly disabled (unable to walk) prior to death, only a minority, however, had become so within 10 years of the onset (10%). Sixty two per cent of the patients died of complications of multiple sclerosis. No unusual excess of any disease was noted amongst other causes. As expected, the majority of patients (55%) had bronchopneumonia as the terminal event, 11% had septicaemia, 15% had myocardial infarction and 4% had documented pulmonary embolism. This is the largest series of its kind where prognosis, judged by survival period, has been assessed amongst all multiple sclerosis patients derived from a prevalence sample and observed till death.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • IPSEN J., Jr Life expectancy and probable disability multiple sclerosis. N Engl J Med. 1950 Dec 7;243(23):909–913. [PubMed]
  • CARTER S, SCIARRA D, MERRITT HH. The course of multiple sclerosis as determined by autopsy proven cases. Res Publ Assoc Res Nerv Ment Dis. 1950;28:471–511. [PubMed]
  • LAZARTE JA. Multiple sclerosis: prognosis for ambulatory and nonambulatory patients. Res Publ Assoc Res Nerv Ment Dis. 1950;28:512–523. [PubMed]
  • ALLISON RS. Survival in disseminated sclerosis: a clinical study of a series of cases first seen 20 years ago. Brain. 1950;73(1):103–120. [PubMed]
  • MCALPINE D. The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain. 1961 Jun;84:186–203. [PubMed]
  • HYLLESTED K. Lethality, duration, and mortality of disseminated sclerosis in Denmark. Acta Psychiatr Scand. 1961;36:553–564. [PubMed]
  • Leibowitz U, Kahana E, Alter M. Survival and death in multiple sclerosis. Brain. 1969 Mar;92(1):115–130. [PubMed]
  • Percy AK, Nobrega FT, Okazaki H, Glattre E, Kurland LT. Multiple sclerosis in Rochester, Minn. A 60-year appraisal. Arch Neurol. 1971 Aug;25(2):105–111. [PubMed]
  • Gudmundsson KR. Clinical studies of multiple sclerosis in Iceland. A follow-up of previous survey and reappraisal. Acta Neurol Scand Suppl. 1971;48:1–78. [PubMed]
  • Kurtzke JF, Beebe GW, Nagler B, Kurland LT, Auth TL. Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness. J Chronic Dis. 1977 Dec;30(12):819–830. [PubMed]
  • Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain. 1980 Jun;103(2):281–300. [PubMed]
  • MacLEAN AR, BERKSON J. Mortality and disability in multiple sclerosis; a statistical estimate of prognosis. J Am Med Assoc. 1951 Aug 11;146(15):1367–1369. [PubMed]
  • Kurtzke JF, Beebe GW, Nagler B, Nefzger MD, Auth TL, Kurland LT. Studies on the natural history of multiple sclerosis. V. Long-term survival in young men. Arch Neurol. 1970 Mar;22(3):215–225. [PubMed]
  • Visscher BR, Liu KS, Clark VA, Detels R, Malmgren RM, Dudley JP. Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol Scand. 1984 Nov;70(5):321–328. [PubMed]
  • REINHOLD M. Prognosis in disseminated sclerosis. Br Med J. 1950 Jan 21;1(4646):160–162. [PMC free article] [PubMed]
  • Allen IV, Millar JH, Hutchinson MJ. General disease in 120 necropsy-proven cases of multiple sclerosis. Neuropathol Appl Neurobiol. 1978 Jul-Aug;4(4):279–284. [PubMed]
  • ZIMMERMAN HM, NETSKY MG. The pathology of multiple sclerosis. Res Publ Assoc Res Nerv Ment Dis. 1950;28:271–312. [PubMed]
  • Shepherd DI, Downie AW. Prevalence of multiple sclerosis in north-east Scotland. Br Med J. 1978 Jul 29;2(6133):314–316. [PMC free article] [PubMed]
  • Shepherd DI, Downie AW. A further prevalence study of multiple sclerosis in north-east Scotland. J Neurol Neurosurg Psychiatry. 1980 Apr;43(4):310–315. [PMC free article] [PubMed]
  • Downie AW, Phadke JG. The chief scientist reports ... multiple sclerosis in North East Scotland. Health Bull (Edinb) 1984 May;42(3):151–156. [PubMed]
  • McALPINE D, COMPSTON N. Some aspects of the natural history of disseminated sclerosis. Q J Med. 1952 Apr;21(82):135–167. [PubMed]
  • Hutchinson WM. Acute optic neuritis and the prognosis for multiple sclerosis. J Neurol Neurosurg Psychiatry. 1976 Mar;39(3):283–289. [PMC free article] [PubMed]
  • POECK K, MARKUS P. GIBT ES EINE GUTARTIGE VERLAUFSFORM DER MULTIPLEN SKLEROSE? Munch Med Wochenschr. 1964 Nov 27;106:2190–2197. [PubMed]
  • Thompson AJ, Hutchinson M, Brazil J, Feighery C, Martin EA. A clinical and laboratory study of benign multiple sclerosis. Q J Med. 1986 Jan;58(225):69–80. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group